Ergoteles’s Barclays BCS Stock Holding History

Ergoteles’s Portfolio BCS Stock Details BCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,109	Closed	-$410K	–	1452
2022 Q3	$410K	Buy	64,109 +47,798	+293%	+$368K	0.01%	834
2022 Q2	$124K	Buy	+16,311	New	+$128K	﹤0.01%	1460
2022 Q1	–	Sell	-41,207	Closed	-$426K	–	1225
2021 Q4	$426K	Buy	+41,207	New	+$432K	0.02%	705

Other funds holding BCS

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ergoteles's BCS Position: Q4 2022 in Review

Ergoteles sold out of Barclays (BCS) in Q4 2022, closing a stake of 64,109 shares — an estimated $410K sold.

Ergoteles first reported a position in BCS in Q4 2021 and held it in 3 quarters. The position peaked at $426K in Q4 2021. 303 funds tracked by Wall St. Rank hold BCS as of Q4 2022.

Ergoteles reported no remaining Barclays position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 64,109 Barclays shares in Q4 2022, an estimated $410K.
Ergoteles first reported a position in Barclays in Q4 2021 and held it in 3 quarters.
Ergoteles's Barclays position peaked at $426K in Q4 2021.
303 funds tracked by Wall St. Rank held Barclays as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.